Our results demonstrated that H101 treatment significantly inhibited the growth of CAR-positive cells, U87-MG and T24 cells, while anti-PD-1 treatment inhibited the tumor growth of CAR-positive cells, U87-MG and T24 cells. Here, PDCD1 is linked to neoplasm.